Johnson & Johnson (@JNJGlobalHealth) is unjustly extending a patent on a life-saving tuberculosis drug. Today's the day for them to realize denying MDR-TB patients treatment is not worth the harm they're causing to core brands like Tylenol and Neutrogena. https://t.co/JArPHWpmv5
— John Green (@sportswithjohn) July 11, 2023